Lu Lu

20.3k total citations · 8 hit papers
305 papers, 11.8k citations indexed

About

Lu Lu is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lu Lu has authored 305 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Infectious Diseases, 71 papers in Virology and 59 papers in Epidemiology. Recurrent topics in Lu Lu's work include HIV Research and Treatment (69 papers), SARS-CoV-2 and COVID-19 Research (61 papers) and HIV/AIDS drug development and treatment (50 papers). Lu Lu is often cited by papers focused on HIV Research and Treatment (69 papers), SARS-CoV-2 and COVID-19 Research (61 papers) and HIV/AIDS drug development and treatment (50 papers). Lu Lu collaborates with scholars based in China, United States and Hong Kong. Lu Lu's co-authors include Shibo Jiang, Shuai Xia, Lanying Du, Wei Xu, Yun Zhu, Tianlei Ying, Zheng‐Li Shi, Yanling Wu, Qiaoshuai Lan and Qian Wang and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lu Lu

290 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

2020 978 citations Shuai Xia, Chao Wang et al. profile →
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

2020 838 citations Xiaolong Tian, Cheng Li et al. Emerging Microbes & Infections profile →
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

2020 518 citations Shuai Xia, Yun Zhu et al. profile →
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

2019 374 citations Shuai Xia, Wei Xu et al. profile →
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

2021 334 citations Wei Xu, Shibo Jiang et al. profile →
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade

2019 333 citations Da Xu, Yan Zheng et al. profile →
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

2014 317 citations Lu Lu, Yun Zhu et al. Nature Communications profile →
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

2021 234 citations Lu Lu, Bobo Wing-Yee Mok et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Lu Lu

Since Specialization

Citations

This map shows the geographic impact of Lu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Lu more than expected).

Fields of papers citing papers by Lu Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Lu. The network helps show where Lu Lu may publish in the future.

Co-authorship network of co-authors of Lu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Lu. A scholar is included among the top collaborators of Lu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Lu. Lu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of maternal health literacy, family functioning and self-efficacy on antepartum depression in pregnant women in China: a moderated mediation model 2025 ·BMC Psychiatry ·Ling Zhang, (unknown), (unknown), Haiyan Qiu, Yang Hong, Xiaolan Shi, (unknown), Chuanfen Zheng, Fengju Li, Ting Luo, Lu Lu, (unknown), Dali Yi, Jian Chen	1
2	A Self-Supervised Multi-Agent Large Language Model Framework for Customized Traffic Mobility Analysis Using Machine Learning Models 2025 ·Transportation Research Record Journal of the Transportation Research Board ·(unknown), Xiaoyue Cathy Liu, Lu Lu, (unknown), Chenxi Liu	1
3	Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression 2024 ·Scientific Reports ·Lu Lu, Mingjie Chen, Guicheng Zhang, Yujing Liu, (unknown), Zhi Jiang, Yangxian Xu, Tao Liu, Fan Yang, Guang Ji, Hanchen Xu	1
4	Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma 2024 ·Cell Reports Medicine ·Shun Wang, (unknown), (unknown), (unknown), Yan Zheng, Da Xu, (unknown), Ze Zhang, Yan Fu, Hao Wang, Xufeng Wang, Tiantian Zou, Xiaotian Shen, Lumin Zhang, (unknown), Lu Lu, Lun–Xiu Qin, Qiongzhu Dong	42
5	Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Luyu Yang, Xiaotian Shen, Junjie Pan, Yiran Chen, (unknown), Hao Wang, Jiaqi Meng, (unknown), Sun‐Zhe Xie, (unknown), (unknown), Wenwei Zhu, Lun–Xiu Qin, Lu Lu	8
6	A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses 2024 ·Nature Communications ·Ying-Dan Wang, (unknown), Ping Ji, (unknown), Zhaoyong Zhang, Jiali Chen, (unknown), (unknown), (unknown), (unknown), Yanqun Wang, Yu‐Mei Wen, Lu Lu, Zhenguo Chen, Jincun Zhao, Fan Wu, Jinghe Huang, Lei Sun	6
7	QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study 2024 ·Signal Transduction and Targeted Therapy ·Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Yaxiong Zhang, (unknown), Ting Zhou, Gang Chen, Ting Wu, Lu Lu, (unknown), Xiaoyan Kang, Li Zhang, Wenfeng Fang	10
8	An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer 2023 ·Frontiers in Oncology ·(unknown), (unknown), Lu Lu	4
9	Predicting the efficacy of immune checkpoint inhibitors monotherapy in advanced non-small cell lung cancer: a machine learning method based on multidimensional data 2023 ·Neoplasma ·Na Liu, (unknown), Lu Lu, (unknown), Jingjing Sun, (unknown), Jie Xu, (unknown), Lei Shi	1
10	A multi-scale perceptual polyp segmentation network based on boundary guidance 2023 ·Image and Vision Computing ·Lu Lu, Shuhan Chen, (unknown), (unknown), Xuelong Hu	12
11	Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients breakdown → 2021 ·Clinical Infectious Diseases ·Lu Lu, Bobo Wing-Yee Mok, (unknown), Jacky Man Chun Chan, O. T. Y. Tsang, Bosco Lam, (unknown), (unknown), (unknown), Jonathan Daniel Ip, (unknown), Ruiqi Zhang, (unknown), Vincent Chi‐Chung Cheng, Kwok Hung Chan, Dong‐Yan Jin, Ivan Fan Ngai Hung, Kwok Yung Yuen, Honglin Chen, (unknown)	234
12	Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type III for the rapid repair of infected chronic diabetic wounds 2021 ·Journal of Materials Chemistry B ·Cheng Hu, Wenqi Liu, Linyu Long, Zhicun Wang, Yihui Yuan, Wen Zhang, Shuyi He, Jian Wang, Li Yang, Lu Lu, Yunbing Wang	53
13	Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection 2021 ·Journal of Medicinal Chemistry ·Chao Wang, (unknown), (unknown), Yue Li, Huan Wang, Rong Xiang, (unknown), Qiaoshuai Lan, Ruiying Liang, Qing Li, Shanshan Huo, Lu Lu, Qian Wang, Fei Yu, Keliang Liu, Shibo Jiang	13
14	Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity 2020 ·Science ·Ji Wang, Peiyu Li, Yang Yu, YuHong Fu, Hongye Jiang, Min Lu, Zhiping Sun, Shibo Jiang, Lu Lu, Mei X. Wu	237
15	Exosomes Derived from Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Inhibiting Pyroptosis 2020 ·SHILAP Revista de lepidopterología ·Jie Tang, Jin Liu, (unknown), (unknown), Yun Ma, Lu Lu, Jinghong Ma, Peng Ding, Xiaoyu Yang, Jiaqi Liu, (unknown)	1
16	An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells 2020 ·Science Translational Medicine ·Qian Wang, Shan Su, Jing Xue, Fei Yu, Jing Pu, (unknown), Shuai Xia, (unknown), (unknown), Wenqian Yang, Wei Xu, Yun Zhu, (unknown), Chuan Qin, Shibo Jiang, Lu Lu	11
17	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody breakdown → 2020 ·Emerging Microbes & Infections ·Xiaolong Tian, Cheng Li, Ailing Huang, Shuai Xia, (unknown), Zheng‐Li Shi, Lu Lu, Shibo Jiang, Zhenlin Yang, Yanling Wu, Tianlei Ying	838
18	Design and Biological Evaluation of m-Xylene Thioether-Stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled–Coil Fusion Complex 2019 ·Journal of Medicinal Chemistry ·(unknown), Jing Pu, Yue Li, (unknown), (unknown), Wei Xu, Tianhong Zhang, Xue Li, Lu Lu, Chao Wang, Shibo Jiang, Keliang Liu	17
19	QTLand systems genetics analysis of mouse grooming and behavioral responses to novelty in an open field 2017 ·Genes Brain & Behavior ·Anna Delprato, (unknown), (unknown), Jason A. Bubier, Lu Lu, Robert W. Williams, (unknown), Wim E. Crusio	18
20	Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease 2015 ·Journal of Virology ·Xinrong Tao, Tania Garron, Anurodh Shankar Agrawal, Abdullah Algaissi, Bi-Hung Peng, Maki Wakamiya, Teh‐Sheng Chan, Lu Lu, Lanying Du, Shibo Jiang, Robert B. Couch, Chien‐Te K. Tseng	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact